(S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (ADJP (ADJP (JJ Native)) (CC and) (ADJP (VBN Degraded))) (NN CGN))) (PP (IN on) (NP (NP (NN THP-1) (NN Proliferation)) (CC and) (NP (NN Cell) (NN Cycle)))))))
(S1 (S (S (NP (NP (JJ Preliminary) (NNS observations)) (PP (IN by) (NP (NP (NN enumeration)) (PP (IN of) (NP (NP (NN THP-1) (NNS cells)) (VP (VBN exposed) (PP (TO to) (NP (NP (JJ different) (NNS concentrations)) (PP (IN of) (NP (NP (ADJP (JJ native))) (CC and) (NP (NP (NN dCGN)) (PRN (-LRB- -LRB-) (NP (QP (CD 10) (CC and) (CD 40)) (NN kDa)) (-RRB- -RRB-))))))) (PP (IN during) (NP (CD 2) (, ,) (CD 5) (CC and) (CD 7) (NNS days)))))))) (, ,)) (VP (VBD showed) (NP (NP (DT a) (NN decline)) (PP (IN in) (NP (NN cell) (NN number)))) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBD suggested) (SBAR (IN that) (S (NP (NN dCGN)) (VP (MD might) (VP (VB cause) (NP (NP (DT an) (NN alteration)) (PP (IN in) (NP (DT the) (NN cell) (NN cycle)))))))))) (. .)))
(S1 (S (NP (NP (NN Cell) (NN cycle) (NN analysis)) (VP (VBG using) (NP (NN flow) (NN cytometry)))) (VP (VBD showed) (NP (NP (DT an) (NN accumulation)) (PP (IN of) (NP (NN THP-1) (NNS cells))) (PP (IN in) (NP (NN G0/G1) (NN phase))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN decrease) (NN number)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN in) (NP (NP (DT the) (NN S) (NN phase)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3A)) (-RRB- -RRB-)))))))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN percentage)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN in) (NP (DT the) (NN G0/G1) (NN phase)))))) (VP (VBD was) (NP (NP (NP (CD 45.2) (NN %)) (PP (IN for) (NP (NN control) (NNS cells)))) (, ,) (NP (NP (CD 62.6) (NN %)) (PP (IN for) (NP (NP (NN C10) (NN dCGN)) (PRN (-LRB- -LRB-) (PP (IN at) (NP (CD 2) (NN mg/ml))) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NP (CD 64.2) (NN %)) (PP (IN for) (NP (NP (NP (NN C40) (JJ dCGN-treated) (NNS cells)) (PRN (-LRB- -LRB-) (PP (IN at) (NP (CD 2) (NN mg/ml))) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3B)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN dCGN))) (PP (IN on) (NP (NN cell) (NN cycle)))) (VP (VBD was) (ADJP (ADJP (JJ dose-dependent)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 3B)) (-RRB- -RRB-))))) (. .)))
(S1 (S (S (NP (CC Neither) (NP (ADJP (JJ native))) (CC nor) (NP (ADJP (JJ dCGN)))) (VP (VBD had) (NP (DT an) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS cells)) (PP (IN in) (NP (NP (DT the) (NN G2/M) (NN phase)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (CD 3)) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN effect)) (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (NN cytotoxicity)) (PP (IN of) (NP (NN dCGN)))))) (PP (ADVP (RB even)) (IN at) (NP (NP (DT the) (JJS highest) (NN concentration)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (NP (CD 2) (NN mg/ml)) (-RRB- -RRB-)))) (SBAR (IN since) (S (NP (NN cell) (NN viability)) (VP (VBD was) (RB not) (VP (VBN affected) (PRN (-LRB- -LRB-) (S (NP (NNS data)) (VP (RB not) (VBN shown))) (-RRB- -RRB-)))))))) (. .)))
